Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/19/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. AAPL
7. RTB
8. AZN
9. SPCX
10. TRMD

Go back to Amgen's First Quarter 2015 Revenues Increased 11 Percent To $5.0 Billion And Adjusted Earnings Per Share (EPS) Increased 33 Percent To $2.48

Amgen (AMGN) Price Target Raised to $195 at Jefferies

April 22, 2015 11:41 AM EDT

In a note earlier, Jefferies analyst Eun K. Yang reiterated a Buy rating and boosted his price target on Amgen (NASDAQ: AMGN) to $195.00 (from $182.00) following Q1 results.

Yang commented, "Reported ~18% higher EPS (vs. cons) on ~3% higher product sales & lower OpEx; upped FY15 EPS guidance... More

Amgen (AMGN) Price Target Lifted to $187 at Leerink Partners

April 22, 2015 7:49 AM EDT

Leerink Partners analyst Howard Liang reiterated an Outperform rating and boosted estimates and his price target on Amgen (NASDAQ: AMGN) to $187.00 (from $177.00) following strong results.

Liang commented, "AMGN reported a strong first quarter last night, with a broad range of products contributing to a ~$117M sales beat vs. consensus and approximately twice this number in lower-than-expected operating expenses, leading to... More

Amgen (AMGN) Tops Q1 EPS by 38c; Boosts FY15 Outlook

April 21, 2015 4:03 PM EDT

Amgen (NASDAQ: AMGN) reported Q1 EPS of $2.48, $0.38 better than the analyst estimate of $2.10. Revenue for the quarter came in at $5.03 billion versus the consensus estimate of $4.91 billion.

Amgen sees FY2015 EPS of $9.35 - $9.65, versus the consensus of $9.32. Amgen sees FY2015 revenue of $20.9 - $21.3... More